Stomach Cancer Tissue Array With Matched Adjacent Normal Stomach Tissue, Including TNM And Clinical Stage, 40 Cases/80 Cores, Replacing ST801|ヒト組織アレイ

掲載日情報:2015/08/07 現在Webページ番号:173961

US Biomax社は、豊富なラインナップの組織アレイ、組織切片(凍結、FFPE)を提供しているメーカーです。
US Biomax社のヒト組織アレイ(Stomach Cancer Tissue Array With Matched Adjacent Normal Stomach Tissue, Including TNM And Clinical Stage, 40 Cases/80 Cores, Replacing ST801)をご紹介します。

ヒト組織アレイは、ドナーからインフォームドコンセントを取得した組織を使用しています。
ドナーの組織は、HIV、Hepatitis B、Hepatitis Cが陰性であることを確認しています。
本製品は研究用です。研究用以外には使用できません。

ヒト組織アレイの価格

[在庫・価格 :2024年05月16日 19時35分現在]

※ 表示されている納期は弊社に在庫が無く、取り寄せた場合の納期目安となります。
詳細 商品名
  • 商品コード
  • メーカー
  • 包装
  • 価格
  • 在庫
  • 法規制等
納期 文献数
Stomach cancer tissue array with matched adjacent normal stomach tissue, including TNM and clinical stage, 40 cases/・・・
2~3週間 ※ 表示されている納期は弊社に在庫がなく、取り寄せた場合の目安納期となります。 0

[在庫・価格 :2024年05月16日 19時35分現在]

※ 表示されている納期は弊社に在庫が無く、取り寄せた場合の納期目安となります。

Stomach cancer tissue array with matched adjacent normal stomach tissue, including TNM and clinical stage, 40 cases/・・・

文献数: 0

目次に戻る

ヒト組織アレイの特長

Microarray Panel: Gastric adenocarcinoma with matched adjacent normal tissue microarry, containing 36 cases of stomach adenocarcinoma, 2 stomach mucinous adenocarcinoma, 1 each of stomach signet ring cell carcinoma and carcinoid, duplicate cores per case
Cores: 80
組織アレイ
Cases: 40
Layout: 10 cols × 8 rows
Core Diameter: 1.5 mm
Thickness: 5 µm
Quality Control: Anti-Actin confirmed
Applications:

Routine histology procedures including ImmunoHistochemistry (IHC) and In Situ Hybridization (ISH), protocols which can be found on our support page.

Notes: Unless specified, all TMA slides are not coated with extra layer of paraffin (tissue cores can be easily seen on the glass), so there is no need to bake, can be directly put into xylene for de-paraffin procedure.

*Tissue Microarray Slide Types:

  • Unstained: unstained paraffin tissue microarray slide.
  • Trial: tissue microarray trial slide. 10% - 25% of cores missing. Good for titrating antibody dilution and experiment conditions. Limited numbers are available, to 2 per item per order. Test slides (tissue arrays with catalog numbers ending with 241 or 242) are recommended as a substitute.
  • H and E: Hematoxylin and Eosin stained tissue array slide.

目次に戻る

ヒト組織アレイの仕様表

Pos No. Sex Age Organ Pathology diagnosis Grade Stage TNM Type †
A1 1 F 78 Stomach Adenocarcinoma 1 II T3N0M0 Malignant
A2 2 F 78 Stomach Cancer adjacent normal stomach tissue NAT
A3 3 M 67 Stomach Adenocarcinoma (sparse) 1 IB T2N0M1 Malignant
A4 4 M 67 Stomach Cancer adjacent normal stomach tissue NAT
A5 5 F 59 Stomach Adenocarcinoma 1 II T3N0M0 Malignant
A6 6 F 59 Stomach Cancer adjacent normal stomach tissue NAT
A7 7 M 50 Stomach Mucinous adenocarcinoma 1 II T3N0M0 Malignant
A8 8 M 50 Stomach Cancer adjacent normal stomach tissue with chronic inflammation NAT
A9 9 F 51 Stomach Adenocarcinoma 1 II T3N0M0 Malignant
A10 10 F 51 Stomach Cancer adjacent normal stomach tissue NAT
B1 11 F 68 Stomach Adenocarcinoma 2 Ib T2N0M0 Malignant
B2 12 F 68 Stomach Moderate atrophic gastritis NAT
B3 13 M 48 Stomach Adenocarcinoma 1 Ib T2N0M0 Malignant
B4 14 M 48 Stomach Cancer adjacent normal stomach tissue NAT
B5 15 M 56 Stomach Adenocarcinoma 2 IB T2bN0M0 Malignant
B6 16 M 56 Stomach Cancer adjacent normal stomach tissue NAT
B7 17 M 57 Stomach Adenocarcinoma 2 IB T2bN0M0 Malignant
B8 18 M 57 Stomach Cancer adjacent normal stomach tissue NAT
B9 19 M 74 Stomach Adenocarcinoma 2 II T3N0M0 Malignant
B10 20 M 74 Stomach Cancer adjacent normal stomach tissue NAT
C1 21 M 52 Stomach Adenocarcinoma 2 II T3N0M0 Malignant
C2 22 M 52 Stomach Cancer adjacent normal stomach tissue NAT
C3 23 M 68 Stomach Adenocarcinoma 2 II T3N0M0 Malignant
C4 24 M 68 Stomach Cancer adjacent normal stomach tissue NAT
C5 25 M 51 Stomach Adenocarcinoma 2 II T3N0M0 Malignant
C6 26 M 51 Stomach Cancer adjacent normal stomach tissue NAT
C7 27 F 55 Stomach Adenocarcinoma 2 II T3N0M0 Malignant
C8 28 F 55 Stomach Cancer adjacent normal stomach tissue NAT
C9 29 M 53 Stomach Adenocarcinoma 2 II T3N0M0 Malignant
C10 30 M 53 Stomach Cancer adjacent normal stomach tissue NAT
D1 31 M 54 Stomach Adenocarcinoma 2 Ib T2N0M0 Malignant
D2 32 M 54 Stomach Cancer adjacent normal stomach tissue NAT
D3 33 M 69 Stomach Adenocarcinoma 2 II T3N0M0 Malignant
D4 34 M 69 Stomach Cancer adjacent normal stomach tissue NAT
D5 35 M 72 Stomach Adenocarcinoma 3 II T3N0M0 Malignant
D6 36 M 72 Stomach Cancer adjacent normal stomach tissue NAT
D7 37 M 56 Stomach Adenocarcinoma 3 II T3N0M0 Malignant
D8 38 M 56 Stomach Cancer adjacent normal stomach tissue NAT
D9 39 F 53 Stomach Adenocarcinoma 3 II T3N0M0 Malignant
D10 40 F 53 Stomach Cancer adjacent normal stomach tissue NAT
E1 41 M 61 Stomach Adenocarcinoma 2 IIIA T3N1M0 Malignant
E2 42 M 61 Stomach Cancer adjacent normal stomach tissue with chronic inflammation NAT
E3 43 M 49 Stomach Adenocarcinoma 2 II T3N0M0 Malignant
E4 44 M 49 Stomach Cancer adjacent normal stomach tissue NAT
E5 45 M 53 Stomach Adenocarcinoma 3 II T3N0M0 Malignant
E6 46 M 53 Stomach Cancer adjacent normal stomach tissue NAT
E7 47 M 54 Stomach Adenocarcinoma 3 II T3N0M0 Malignant
E8 48 M 54 Stomach Cancer adjacent normal stomach tissue NAT
E9 49 M 50 Stomach Adenocarcinoma 3 II T3N0M0 Malignant
E10 50 M 50 Stomach Moderate atrophic gastritis with intestinal metaplasia NAT
F1 51 F 63 Stomach Adenocarcinoma 3 II T3N0M0 Malignant
F2 52 F 63 Stomach Cancer adjacent normal stomach tissue NAT
F3 53 F 68 Stomach Adenocarcinoma 3 I T2N0M0 Malignant
F4 54 F 68 Stomach Cancer adjacent normal stomach tissue NAT
F5 55 M 71 Stomach Adenocarcinoma 3 IIIA T3N1M0 Malignant
F6 56 M 71 Stomach Cancer adjacent normal stomach tissue NAT
F7 57 M 61 Stomach Adenocarcinoma 3 Ib T2N0M0 Malignant
F8 58 M 61 Stomach Cancer adjacent normal stomach tissue NAT
F9 59 M 47 Stomach Adenocarcinoma (sparse) 3 II T2N1M0 Malignant
F10 60 M 47 Stomach Cancer adjacent normal stomach tissue NAT
G1 61 M 58 Stomach Mucinous adenocarcinoma 3 II T3N0M1 Malignant
G2 62 M 58 Stomach Cancer adjacent normal stomach tissue NAT
G3 63 F 63 Stomach Adenocarcinoma 3 Ib T2N0M0 Malignant
G4 64 F 63 Stomach Cancer adjacent normal stomach tissue NAT
G5 65 M 66 Stomach Adenocarcinoma 3 Ib T2N0M0 Malignant
G6 66 M 66 Stomach Cancer adjacent normal stomach tissue NAT
G7 67 M 52 Stomach Adenocarcinoma 3 Ib T2N0M0 Malignant
G8 68 M 52 Stomach Cancer adjacent normal stomach tissue (sparse) NAT
G9 69 F 54 Stomach Adenocarcinoma 3 IIIB T4N1M0 Malignant
G10 70 F 54 Stomach Cancer adjacent normal stomach tissue NAT
H1 71 F 51 Stomach Adenocarcinoma 3 IIIa T3N1M0 Malignant
H2 72 F 51 Stomach Cancer adjacent normal stomach tissue NAT
H3 73 M 64 Stomach Signet-ring cell carcinoma II T3N0M0 Malignant
H4 74 M 64 Stomach Cancer adjacent normal stomach tissue NAT
H5 75 M 73 Stomach Adenocarcinoma 3 Ib T2N0M0 Malignant
H6 76 M 73 Stomach Cancer adjacent normal stomach tissue NAT
H7 77 M 62 Stomach Carcinoid IIIa T3N1M0 Malignant
H8 78 M 62 Stomach Cancer adjacent normal stomach tissue NAT
H9 79 M 50 Stomach Adenocarcinoma (smooth muscle tissue) IIIa T4N0M0 Malignant
H10 80 M 50 Stomach Cancer adjacent normal stomach tissue NAT
M 42 Adrenal gland Pheochromocytoma (tissue marker) Malignant

*For precise diagnosis, refer to pathology description.

目次に戻る

ヒト組織アレイのFAQ

目次に戻る

お問い合わせ先

(テクニカルサポート 試薬担当)

reagent@funakoshi.co.jp

製品情報は掲載時点のものですが、価格表内の価格については随時最新のものに更新されます。お問い合わせいただくタイミングにより製品情報・価格などは変更されている場合があります。
表示価格に、消費税等は含まれていません。一部価格が予告なく変更される場合がありますので、あらかじめご了承下さい。